iiinova — where your digital self keeps evolving

Reposted by Christina Yap

ICR-CTSU @icr-ctsu.bsky.social · 27/03/2026

The OPTIMISE‑AR paper was published in @thelancetoncol.bsky.social last week. This introduces a practical toolkit to support the analysis and visualisation of patient‑reported outcomes (PROs) in early‑phase dose‑finding oncology trials. 🧪

151

Reposted by Christina Yap

Academy of Medical Sciences @acmedsci.bsky.social · 15/08/2025

Congratulations to Cross-Sector Experience Award recipient @christinayap.bsky.social 🎉 Through this award Prof Yap will work with AstraZeneca & Bayer to improve the design of early-phase trials, ensuring they are more effective & impactful for patients. 👉 bit.ly/45a0VWy #CrossSector @icr.ac.uk

Professor Christina Yap, Academy Cross-Sector Experience Awardee, next to a quote that reads: "I’m thrilled to collaborate with AstraZeneca and Bayer through placements, advancing statistical methods to improve early-phase trials and patient-centred outcomes."

052

Christina Yap @christinayap.bsky.social · 19/05/2025

A real pleasure running this workshop with you and Devin Peipert - thank you so much! Had such an engaging and interactive group too!

030

Christina Yap @christinayap.bsky.social · 13/05/2025

Thank you for the kind invitation to share insights on the value of PROs in phase I dose-finding trials. A fantastic conference in the beautiful city of Barcelona - I’ve learnt so much too! Such a privilege to be part of it!

032

Christina Yap @christinayap.bsky.social · 18/01/2025

Passionate about cancer trials, patient-reported outcomes (PROs) & innovative methods? Join the Early Phase and Adaptive Trials Group at @icr-ctsu.bsky.social @icrlondon.bsky.social for an exciting undergraduate summer scholarship in early phase trials & PROs! Deadline: 26/01/25 shorturl.at/1h565

icr.ac.uk

Undergraduate Summer Scholarship Scheme - The Institute of Cancer Research, London

Our paid undergraduate summer scholarships offer undergraduate students a chance to gain hands-on cancer research experience.

046